ReShape Lifesciences (RSLS) Q4 2024 Earnings

Nov 14Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-6.96
-4.69
-2.43
-0.16

Details

Expected EPS
-5.8
Actual EPS
-3.023531
Surprise EPS
2.78
Surprise Percent
+47.87%

Description

⁨ReShape Lifesciences⁩ (⁦RSLS⁩) has reported earnings of ⁦-3.023531⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts